Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference

2020 ◽  
pp. ijgc-2020-001652
Author(s):  
William Small Jr ◽  
Gheorghe Peltecu ◽  
Anastasia Puiu ◽  
Andrei Corha ◽  
Elena Cocîrṭă ◽  
...  

Cervical cancer is the third most common cancer among women worldwide, with a disproportionately high burden of disease in less-developed regions of the world. The Cervix Cancer Research Network was founded by the Gynecologic Cancer InterGroup with a mission to improve outcomes in cervical cancer by enhancing international access to clinical trials, specifically in under-represented, underdeveloped areas. The Cervix Cancer Research Network held its third international educational symposium in Bucharest in 2018 and is the subject of this report. The purpose of this symposium was to advance the international understanding of cervical cancer treatment patterns, to foster recruitment to Cervix Cancer Research Network clinical trials, and identify key Cervix Cancer Research Network clinical trial concepts to improve cervical cancer care worldwide.

2016 ◽  
Vol 26 (9) ◽  
pp. 1690-1693 ◽  
Author(s):  
David Gaffney ◽  
Bill Small ◽  
Henry Kitchener ◽  
Sang Young Ryu ◽  
Akila Viswanathan ◽  
...  

AbstractEighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.


2015 ◽  
Vol 92 (3) ◽  
pp. 506-508 ◽  
Author(s):  
David K. Gaffney ◽  
Gita Suneja ◽  
Sang Young Ryu ◽  
Mary McCormick ◽  
Marie Plante ◽  
...  

2021 ◽  
Vol 31 (5) ◽  
pp. 775-778
Author(s):  
Mary McCormack ◽  
David Gaffney ◽  
David Tan ◽  
Kathy Bennet ◽  
Adriana Chavez-Blanco ◽  
...  

Cervical cancer is a global health problem which disproportionally affects women in low- and middle- income countries. The World Health Organization recently launched its global strategy to eliminate this disease in the next two decades. For those women diagnosed today with cervical cancer better strategies are needed to improve outcome and reduce treatment-related morbidity. Clinical trials are critical to shaping future treatment, and much has been achieved already. However, such opportunities are limited in low resource settings, and the Cervical Cancer Research Network is dedicated to expanding access to new technologies in surgery, radiation, and medical oncology. In this article we review the status of the trials portfolio and outline future objectives, including the launch of a number of research grants for aspiring or established researchers in low- and middle-income settings


2018 ◽  
Vol 25 ◽  
pp. 90-93 ◽  
Author(s):  
Bryan J. Ager ◽  
Dolores Gallardo-Rincón ◽  
David Cantú de León ◽  
Adriana Chávez-Blanco ◽  
Linus Chuang ◽  
...  

2020 ◽  
Vol 9 (6) ◽  
pp. 2146-2152
Author(s):  
Michael E. Roth ◽  
Joseph M. Unger ◽  
Ann M. O'Mara ◽  
Mark A. Lewis ◽  
Troy Budd ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document